コンテンツへスキップ
Merck

[Hepatic dysfunction correction in patients with obturation jaundice].

Klinichna khirurhiia (2013-07-31)
B M Datsenko, T I Tamm, V B Borisenko, K A Kramarenko
要旨

Comparative analysis of results of examination and treatment of 54 patients, suffering obturation jaundice syndrome, is presented. The presence and severity of hepatic dysfunction was determined in accordance to indices of cytolysis and cholestasis syndromes, and its severity--in accordance to V. P. Zinevich criteria (1986). There was established, that timely elimination of obturation jaundice, using miniinvasive interventions and subsequent conduction of complex hepatotropic therapy, using L-ornitin L-aspartate, permits to correct hepatic dysfunction effectively.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
L-オルニチン L-アスパラギン酸塩, powder